SOM

SOMNOMED FPO [SOM]

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.

Healthcare · ASX Small Cap

$0.3450 -2.8%

Updated 3 Sep 2026 · Signals refresh every scan

Appeared in 2 consecutive scansFirst seen: 2026-03-04

Get alerts when SOM triggers a new signal

Free watchlist with daily scans for 2,200+ ASX stocks

Track SOM — Free

Active Signals

Bullish Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is picking up steam
Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
Lagging the Small Ords index — relative strength of 0.84, underperforming its peers
Cash positive / operating cashflow positive
Low P/S ratio (0.7x)
EPS estimates revised upward (+10pts)
Near 52-week low (7% of range)
Small-cap ($20-100M)
CANSLIM S: Tight float (46%)
CANSLIM I: Institutional ownership (62%)
Sentiment is mixed — no strong consensus either way
Beneish M-Score -2.06 (grey zone -2.22 to -1.78): possible earnings manipulation
RBA hiking (-3pts)

Risk Signals

Below the 200-day average — the long-term trend is still working against it
Revenue declining (-7%)
Negative profit margins (-2%)
Not enough chatter to gauge sentiment — defaulting to neutral
Long-term momentum is negative — down 45% over the past year

Ask Scout AI about SOM

"What's driving SOM today?" "How does SOM compare to peers?" "Key risks for SOM?"

3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Change of Director's Interest Notice

Announcement tone +5pts

Recent ASX Announcements

2026-08-28	Change of Director's Interest Notice
2026-08-28	Change of Director's Interest Notice
2026-08-28	Change of Director's Interest Notice
2026-08-28	Change of Director's Interest Notice
2026-08-27	Securities Trading Policy

Key Metrics

$75.8M

Market Cap

59K

Avg Volume

1.1x

Vol Ratio

$0.30 — $0.94

52-Week Range

N/A

Short Interest

N/A

Cash Runway

-5.7%

ROE

-2.3%

Profit Margin

CANSLIM Analysis

	Factor	Rating	Detail
C	Current EPS	fail	EPS Growth: 0%
A	Annual Earnings	fail	CAGR: 0%
N	New Highs / Catalysts	neutral
S	Supply & Demand	pass	Float: 46%
L	Leader vs Laggard	laggard	RS: -17
I	Institutional Sponsorship	pass	Inst: 62%
M	Market Direction	neutral	Neutral

Sector: Healthcare

113 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →

Compare:SOM vs REG SOM vs CAN SOM vs BIT

Scout Pro — Deeper Analysis for SOM

Try Pro free for 30 days

Track SOM and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener

No credit card required